OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
COPY CODE
Description
Cycram 500 mg Injection is an anticancer agent which is used in the treatment of various cancers of the blood and the female reproductive system. It should be used under the supervision of a qualified physician. Close monitoring of kidney function and blood cell count is necessary while receiving this medication.
QUICK LINKS:
Substitutes
List of substitutes for Cycram 500 mg Injection
Cycloxan 500 mg Injection
Zydus Cadila
Cyphos 500 mg Injection
Intas Pharmaceuticals Ltd.
Endoxan 500 mg Injection
Zydus Cadila
Endoxan N 500 mg Injection
Zydus Cadila
Oncophos 500 mg Injection
Cadila Pharmaceuticals Ltd.
Side effects
Major & minor side effects for Cycram 500 mg Injection
- Infections
- Decrease in blood cell count
- Hair loss
- Fever
- Weakness
- Loss of appetite
- Nausea and Vomiting
- Diarrhea
- Headache
- Increased sweating
- Skin rash
Uses of Cycram 500 mg Injection
What is it prescribed for?
- Malignant Disease
- Ovarian Cancer
- Breast cancer
- Nephrotic Syndrome
Read More
Concerns
Commonly asked questions
- Onset of actionThe effect of this medicine can be observed in 2 to 3 hours after an oral dose.
- Duration of effectThe effect of this medicine lasts for an average duration of 12 to 24 hours.
- Safe with alcohol?Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
- Is it habit forming?No habit forming tendency has been reported.
- Usage in pregnancy?This medicine is not recommended for use in pregnant women.
- Usage while breast-feeding?This medicine is not recommended for use in breastfeeding women.
Allergy
Not recommended in patients with known allergy to Cycram 500 mg Injection or other alkylating agents.
Urinary outflow obstruction
Not recommended in patients with conditions that obstruct the urine outflow.
Bone marrow suppression
Not recommended in patients with low blood cell counts.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women.
Breast-feeding
This medicine is not recommended for use in breastfeeding women.
General warnings
Secondary Malignancies
Cycram 500 mg Injection is known to increase the risk of secondary tumors. Most frequently, the urinary tract, thyroid gland, and blood are affected. Close monitoring of signs and symptoms is necessary. The treatment should be discontinued if malignancy develops.
Blood cell count
Cycram 500 mg Injection is known to lower the white blood cell count (neutrophils) and platelets. Close monitoring of blood cell counts is necessary. Do not start the treatment if the neutrophils count is less than 1500 cells/mm3 and platelets count is less than 50,000 cells/mm3.
Effect on heart
Cycram 500 mg Injection may increase the risk of toxic effects on the heart and could lead to congestive heart failure. The treatment should be monitored in patients with a history of heart disease.
Effect on lungs
Cycram 500 mg Injection may increase the risk of toxic effects on lungs and could lead to respiratory failure. Any symptoms of lung toxicity should be informed to the doctor on priority. The treatment should be discontinued if such symptoms appear.
Infections
The chances of infections are more in patients receiving this medicine. Hold the chemotherapy and start with broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary.
Impaired kidney function
Cycram 500 mg Injection is known to increase kidney injury and increases the risk of secondary cancers. It should be used with caution in patients with urinary tract infections. The treatment should be discontinued if the signs and symptoms of kidney injury appear.
Missed Dose
It is advised not to miss any dose. If you miss any dose, you should contact your doctor immediately.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Clozapine
Diltiazem
Warfarin
Live attenuated vaccines and related products
Disease interactions
Disease
Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine as advised by the doctor. It should be given in multiple cycles along with other chemotherapy agents. It is important to receive every scheduled dose. The blood cells count and kidney function should be assessed before starting the treatment. Any signs and symptoms of heart and lung dysfunction should be reported to the doctor on priority.
Miscelleneous
How it works
It works by interfering with the DNA synthesis and inhibiting the tumor growth.
Legal Status
Classification
Category
Alkylating agents
Schedule
Schedule G
Cyclophosphamide - DrugBank [Internet]. Drugbank.ca. 2017 [cited 16 June 2017]. Available from:
[Internet]. 2017 [cited 16 June 2017]. Available from:
DailyMed - Cyclophosphamide capsule [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 16 June 2017]. Available from:
Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 16 June 2017]. Available from:
[Internet]. Toxnet.nlm.nih.gov. 2017 [cited 16 June 2017]. Available from:
Loading related questions...
